Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of a New Cardiac Biomarker Assay

ClinicalTrials.gov ID: NCT01608100

Public ClinicalTrials.gov record NCT01608100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Design Validation Protocol for the Evaluation of ARCHITECT STAT High Sensitive Troponin I Assay

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to evaluate the performance and intended use of a new cardiac biomarker test, Troponin I, in an intended use population. Blood specimens will be tested using the new investigational test that detects the level of Troponin I. Results will be compared to the diagnosis of whether or not an acute myocardial infarction (MI) occurred.

Study identification

NCT ID
NCT01608100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott Diagnostics Division
Industry
Enrollment
1,101 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Aug 2014 (Actual)
Completion
Sep 2014 (Actual)
Last update posted
Mar 17, 2015

2012 – 2014

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Chandler Regional Medical Center Chandler Arizona 85224 —
Stanford University School of Emergency Medicine Palo Alto California 94304 —
Nationwide Laboratory Services Fort Lauderdale Florida 33309 —
John T Mather Memorial Hospital Port Jefferson New York 11777 —
Duke University Medical Center Durham North Carolina 27710 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Pennsylvania State University- Hershey Medical Center Hershey Pennsylvania 17033 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283 —
Hospital Physicians in Clinical Research Austin Texas 78752 —
Hospital Physicians in Clinical Research Bryan Texas 77802 —
Dept of Emergency Medicine University of Virginia Charlottesville Virginia 22908-2877 —
St Joseph Hospital Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01608100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01608100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →